Overview

Vaccine development is a complex and time consuming process that differs from the development of conventional pharmaceuticals. Primarily, vaccines are intended for use in healthy individuals as a preventative measure, requiring a long and rigorous process of research and many years of testing and development prior to clinical trials and regulatory approval. The average time for the development of vaccines to clinical is 12 to 15 years. Vaccine Development: From Concept to Clinic is a detailed overview of the development of new vaccines, covering the entire process and addresses all classes of vaccines from a processing, development and regulatory viewpoint. Utilising successful case studies the book will provide insight to the issues scientists face when producing a vaccine, the steps involved and will serve as an ideal reference tool regarding state-of-the-art vaccine development. This book is an ideal companion for any researchers working in vaccine discovery and development or with an interest in the field.

Full Product Details

Author:   A Krishna Prasad (Citranvi, USA)
Publisher:   Royal Society of Chemistry
Imprint:   Royal Society of Chemistry
Volume:   Volume 3
Weight:   0.645kg
ISBN:  

9781788018777

ISBN 10:   178801877
Pages:   322
Publication Date:   09 November 2022
Audience:   College/higher education ,  Professional and scholarly ,  Tertiary & Higher Education ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Vaccine Development: From Concept to Clinic; Pre-clinical Safety Assessment Considerations for Vaccine Development; Clinical Trials in the Development of Vaccines for Infectious Diseases; Clinical Trials in Immunotherapeutic Vaccine Development; Pathogenesis and Immunity of SARS-CoV-2 and Vaccination Programs against COVID-19; High Throughput Assays for Clinical Development; Virus-like Particle Based Vaccines: GARDASIL®; Cell Culture-based Influenza Vaccine Development; Conjugate Vaccines: Design and Development Considerations; Vaccine Adjuvants: Mechanisms of Action; Development Considerations for Final Dosage Forms: Mucosal Bacterial Vaccines; Exploiting Glycans in Vaccine Design; The PATH Experience in Vaccine Development Partnerships with Manufacturers from Emerging Markets

Reviews

Author Information

Citranvi LLC., USA

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions